Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.16199
Abstract: Key Points Question Is there a difference in survival or toxic effects between the main first-line therapies used for metastatic pancreatic cancer? Findings In this comparative effectiveness study that included 1102 patients, FOLFIRINOX (combined leucovorin… read more here.
Keywords: gemcitabine plus; metastatic pancreatic; plus nab; first line ... See more keywords
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-017-3316-7
Abstract: PurposeThe renal safety of cisplatin-based chemotherapy has not been investigated in patients with urothelial carcinoma of the upper urinary tract (UUT-UC) who retain a solitary kidney after nephroureterectomy. This study aimed to assess and compare… read more here.
Keywords: chemotherapy; renal safety; gemcitabine plus; solitary kidney ... See more keywords
Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First‐Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta‐Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2016.05.003
Abstract: &NA; Although gemcitabine plus carboplatin (GCa) is the conventional first‐line chemotherapy for cisplatin‐ineligible metastatic urothelial carcinoma, its results are suboptimal. A meta‐analysis evaluated the results of gemcitabine with either carboplatin or a taxane (GT). Literature… read more here.
Keywords: first line; analysis; gca; gemcitabine plus ... See more keywords
Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of geriatric oncology"
DOI: 10.1016/j.jgo.2021.06.011
Abstract: OBJECTIVES This study aimed to examine the efficacy and safety of gemcitabine plus nab-paclitaxel (GnP) in older patients with metastatic pancreatic cancer (MPC), especially those ≥75 years old. MATERIALS AND METHODS This study retrospectively enrolled… read more here.
Keywords: nab paclitaxel; group; study; plus nab ... See more keywords
Gemcitabine plus S-1 for metastatic pancreatic cancer
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000012836
Abstract: Abstract To investigate the treatment effects of gemcitabine plus S-1 (GS) for metastatic pancreatic cancer in our institution. Data from 41 patients with metastatic pancreatic cancer treated with GS regimen in West China Hospital, Sichuan… read more here.
Keywords: plus metastatic; metastatic pancreatic; gemcitabine plus; pancreatic cancer ... See more keywords
Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Pancreas"
DOI: 10.1097/mpa.0000000000001826
Abstract: Objectives Although neoadjuvant chemotherapy (NAC)–gemcitabine plus S-1 (GS) has been reported to have a survival benefit in patients with resectable pancreatic ductal adenocarcinoma (PDAC), optimal candidates for NAC-GS have not been clearly identified. Methods A… read more here.
Keywords: chemotherapy; gemcitabine plus; pancreatic ductal; ductal adenocarcinoma ... See more keywords
Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel.
Sign Up to like & getrecommendations! Published in 2022 at "Pancreas"
DOI: 10.1097/mpa.0000000000001985
Abstract: OBJECTIVE The aim of the study was to clarify the association of skeletal muscle mass and the prognosis of unresectable pancreatic ductal adenocarcinoma (PDAC) treated with gemcitabine plus nab-paclitaxel (GnP). METHODS We included 124 unresectable… read more here.
Keywords: sarcopenia; unresectable pancreatic; gemcitabine plus; treated gemcitabine ... See more keywords
Abstract OT2-05-01: A phase II randomized trial of gemcitabine plus cisplatin(GP) vs. gemcitabine plus carboplatin (GC) as the first-line treatment for patients with metastatic triple negative breast cancer
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs17-ot2-05-01
Abstract: Background: Triple-negative breast cancer (TNBC) is an aggressive disease with limited treatment options and poor prognosis . Gemcitabine plus carboplatin (GC) is one of the preferred chemotherapeutic regimens for patients with metastatic triple-negative breast cancer(mTNBC),… read more here.
Keywords: gemcitabine; first line; breast cancer; cancer ... See more keywords
Abstract PO2-06-11: A phase II randomized trial of gemcitabine plus cisplatin(GP) vs gemcitabine plus carboplatin (GC) as the first-line treatment for patients with metastatic triple-negative breast cancer
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs23-po2-06-11
Abstract: Background: Triple-negative breast cancer (TNBC) is an aggressive disease with limited treatment options and poor prognosis. Gemcitabine plus carboplatin (GC) is one of the classic chemotherapeutic regimens for patients with metastatic triple-negative breast cancer(mTNBC) and… read more here.
Keywords: cancer; treatment; gemcitabine plus; group ... See more keywords
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study
Sign Up to like & getrecommendations! Published in 2020 at "BMC Cancer"
DOI: 10.1186/s12885-020-07462-4
Abstract: Background Undifferentiated carcinoma (UC) of the pancreas is a rare subtype of pancreatic cancer. Although UC has been considered a highly aggressive malignancy, no clinical studies have addressed the efficacy of chemotherapy for unresectable UC.… read more here.
Keywords: nab paclitaxel; gemcitabine; study; plus nab ... See more keywords
Complete regression of pulmonary squamous carcinoma in IPF following gemcitabine plus cisplatin: a case report and literature review
Sign Up to like & getrecommendations! Published in 2020 at "BMC Pulmonary Medicine"
DOI: 10.1186/s12890-020-1094-1
Abstract: Background Lung cancer is one of the most common co-morbid conditions in patients with idiopathic pulmonary fibrosis (IPF) and negatively affects the prognosis of IPF; Current guidelines for the management of IPF do not give… read more here.
Keywords: squamous carcinoma; gemcitabine plus; case; following gemcitabine ... See more keywords